Article
Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2012
Tong Lin, Yang Xue-Xi, Liu Min-Feng, Yao Guang-Yu, Dong Jian-Yu, Ye Chang-Sheng, Li Ming
Abstract excerpt
BACKGROUND: The epidermal growth factor receptor (EGFR) is a potential therapeutic target for breast cancer; however, its use does not lead to a marked clinical response. Studies of non-small cell lung cancer and colorectal cancer showed that mutations of genes in the PIK3CA/AKT and RAS/RAF/MEK pathways, two major signalling cascades downstream of EGFR, might predict resistance to EGFR-targeted agents. Therefore,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
